Tenaya Therapeutics Correlations
TNYA Stock | USD 3.29 0.33 11.15% |
The current 90-days correlation between Tenaya Therapeutics and IGM Biosciences is 0.14 (i.e., Average diversification). The correlation of Tenaya Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Tenaya Therapeutics Correlation With Market
Significant diversification
The correlation between Tenaya Therapeutics and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tenaya Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Tenaya |
Moving together with Tenaya Stock
Moving against Tenaya Stock
0.49 | HCM | HUTCHMED DRC | PairCorr |
0.45 | ZTS | Zoetis Inc | PairCorr |
0.44 | GANX | Gain Therapeutics | PairCorr |
0.4 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.44 | APGE | Apogee Therapeutics, | PairCorr |
0.4 | CVS | CVS Health Corp Sell-off Trend | PairCorr |
0.36 | ANEB | Anebulo Pharmaceuticals | PairCorr |
0.36 | SMMT | Summit Therapeutics PLC | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tenaya Stock performing well and Tenaya Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tenaya Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BCYC | 2.34 | (0.26) | 0.00 | (0.03) | 0.00 | 4.68 | 35.92 | |||
IGMS | 5.80 | 0.01 | 0.02 | 0.13 | 6.09 | 11.62 | 41.11 | |||
GLUE | 5.18 | 0.88 | 0.25 | 0.43 | 3.74 | 8.10 | 102.66 | |||
STOK | 2.63 | (0.30) | 0.00 | (0.10) | 0.00 | 4.68 | 21.35 | |||
BMEA | 3.46 | (0.07) | (0.02) | 0.05 | 4.69 | 9.12 | 24.44 | |||
AKRO | 2.37 | 0.09 | 0.07 | 0.17 | 2.62 | 5.23 | 13.37 | |||
FIXX | 2.82 | 0.08 | 0.00 | 0.27 | 3.52 | 5.77 | 19.43 | |||
GOSS | 2.39 | (0.36) | 0.00 | (0.62) | 0.00 | 6.06 | 17.73 | |||
RANI | 5.15 | (0.56) | 0.00 | (0.06) | 0.00 | 8.71 | 90.76 | |||
VINC | 3.97 | (1.46) | 0.00 | (1.15) | 0.00 | 6.06 | 47.76 |
Tenaya Therapeutics Corporate Management
Deepak MD | Chairman Founder | Profile | |
Saptarsi MD | Scientific Founder | Profile | |
Sheng Ding | Scientific Founder | Profile | |
Benoit Bruneau | Scientific Founder | Profile | |
Timothy Hoey | Chief Officer | Profile | |
Leone MBA | Chief Officer | Profile | |
Chihiro Saito | Senior Officer | Profile |